Global Drugmakers Rush for U.S. Presence

If you’ve been watching the news, you might have noticed that big pharma isn’t just waiting around, they’re making moves to stay ahead of potential tariffs. Here’s what investors should know.

Retail Crowding Drives Alpha, Institutions Are Watching

Individual investors are displaying remarkable alpha generation, pulling ahead of the broader market with conviction. However, this surge in trading is making institutional desks nervous that retail’s favorite stocks are becoming dangerously crowded and overvalued.

DoD’s Fluorspar Solicitation Confirms What We Knew: Domestic Suppliers Like Ares Are Critical

We called it. The Defense Logistics Agency’s (DLA) now-closed $250 million solicitation (SP8000-25-R-0020) for acid-grade fluorspar isn’t just another procurement—it’s a neon sign that the U.S. is finally waking up to its critical minerals problem. Since its inception, Endeavour has been highlighting the risks of relying on foreign fluorspar, a linchpin for defense manufacturing from […]

en_USEnglish